Wide Ranks

ARMP

Armata Pharmaceuticals, Inc.

2.30

Top Statistics
Market Cap 83 M Forward PE -1.46 Revenue Growth 0.00 %
Current Ratio 0.25 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -5.30 Enterprise / Revenue 58.27 Price To Sales Trailing12 Months 22.38
Profitability
Profit Margins 0.00 % Operating Margins -1130.87 %
Balance Sheet
Total Cash 26 M Total Cash Per Share 0.7300 Total Debt 146 M
Total Debt To Equity Current Ratio 0.25 Book Value Per Share -0.8880
All Measures
Short Ratio 86.00 % Message Board Id finmb_84546611 Fax 310 665 2963
Shares Short Prior Month 3372 City Los Angeles Uuid e9006f47-0d3e-3b07-8861-14c121fcb2a4
Previous Close 2.35 First Trade Date Epoch Utc 769 M Book Value -0.8880
Beta 0.8050 Total Debt 146 M Volume 6398
Last Split Date 1 B Fifty Two Week Low 1.98 Total Cash Per Share 0.7300
Total Revenue 3 M Shares Short Previous Month Date 1 B Target Median Price 7.00
Max Age 86400 Recommendation Mean 2.00 Sand P52 Week Change 0.3133
Operating Margins -1130.87 % Target Mean Price 7.00 Net Income To Common -67043000
Ask 2.51 Short Percent Of Float 0.0004 Implied Shares Outstanding 36 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 11960
Average Volume10days 11960 Total Cash 26 M Next Fiscal Year End 1 B
Revenue Per Share 0.1030 Held Percent Insiders 0.7025 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 2.35
Target Low Price 7.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.33
Open 2.40 Free Cashflow -31061124 State CA
Dividend Yield 0.00 % Return On Assets -0.2509 Time Zone Short Name EST
Trailing Eps -1.15 Day Low 2.30 Address1 5005 McConnell Avenue
Shares Outstanding 36 M Price Hint 4 Target High Price 7.00
Website https://www.armatapharma.com 52 Week Change 0.0502 Average Volume 7223
Forward Eps -1.57 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 22.40 % Last Split Factor 1:14 Regular Market Day High 2.40
Is_sp_500 False Profit Margins 0.00 % Fifty Two Week High 4.48
Day High 2.40 Shares Short 4540 Regular Market Open 2.40
Industry Key biotechnology Bid 1.98 Earnings Growth 0.00 %
Enterprise To Revenue 58.27 Revenue Growth 0.00 % Shares Percent Shares Out 0.0001
Operating Cashflow -38554000 Currency USD Time Zone Full Name America/New_York
Market Cap 83 M Is_nasdaq_100 False Zip 90066
Quote Type EQUITY Industry Biotechnology Long Name Armata Pharmaceuticals, Inc.
Regular Market Day Low 2.30 Held Percent Institutions 0.0382 Current Price 2.30
Enterprise To Ebitda -5.30 Financial Currency USD Current Ratio 0.25
Industry Disp Biotechnology Number Of Analyst Opinions 1 Country United States
Float Shares 11 M Two Hundred Day Average 2.76 Ir Website http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote
Enterprise Value 216 M Price To Sales Trailing12 Months 22.38 Forward PE -1.46
Regular Market Volume 6398 Ebitda -40911000 Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

It develops its products using its proprietary bacteriophage-based technology.

The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.

It has research collaboration agreement with Merck Sharp & Dohme Corp.

for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents.

The company is headquartered in Los Angeles, California.

Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.